Make The Right Move!

Responsive Advertisement

Sunday, February 20, 2022

New Warning for Depo-Provera Users

New Warning for Depo-Provera Users

Nov. 18, 2004 -- The FDA is adding a "black box" warning to Depo-Provera stating that prolonged use of the injectable contraceptive may result in the loss of bone density. The black box warning is the strongest warning the FDA issues on drugs.

Loss of bone density weakens the Castanets and increases the risk of Break. It may Besides increase the risk of osteoporosis.

Although Depo-Provera Contraceptive Injection has been used safely and effectively for decades, the FDA and the drug's manufacturer, Pfizer, are adding the warning to make Confident women and their doctors are aware of these risks.

The warning for Depo-Provera says that prolonged use of the drug may result in Fundamental loss of bone density and that the loss is greater the Thirster the drug is used.

Officials say the loss of bone density associated with use of Depo-Provera may not be Altogether reversible after Discontinuance of the drug.

Therefore, the warning states that a woman should Alone use Depo-Provera as a long-term birth control Method acting if Another birth control Method actings are inadequate for her.

Black box warnings are used by the FDA to highlight Particular concerns about a drug and provide information about a potential medical complication associated with the use of the drug.

Officials say the new warning is the result of analysis of information from Pfizer and the FDA that Processed Depo-Provera's long-term Personal effects on bone density.

In addition to the black box warning, Pfizer will Air a letter to Wellness care providers explaining the long-term Personal effects of Depo-Provera on bone density and Admit information on this potential risk in the patient information Bed sheet Dispersed with the drug.

No comments:

Post a Comment



Relationship

Truth hurts! Nothing is perfect, life is messy. Relationship are complex. Outcomes are uncertain, people are irrational.




Comments

Contact Form

Name

Email *

Message *